Alzheimer’s expert says more clinical trials are needed for controversial Biogen drug
December 06, 2019 at 15:08 PM EST
An Alzheimer’s disease expert said Biogen “absolutely” needs to conduct a third clinical trial for aducanumab, its now controversial and recently resurrected Alzheimer’s disease drug candidate.
